Literature DB >> 16176203

Decreased isometric muscle strength after acute hyperglycaemia in Type 1 diabetic patients.

H Andersen1, O Schmitz, S Nielsen.   

Abstract

AIMS: Fatigue is a common complaint in diabetic patients during periods of hyperglycaemia. To test whether muscle performance is reduced during acute hyperglycaemia, diabetic patients were studied whilst performing maximal isokinetic and isometric contractions.
METHODS: In this double-blind placebo controlled study, maximal isometric and isokinetic muscle strength was determined in seven Type 1 diabetic patients during normo- and hyperglycaemia using a hyperglycaemic clamp technique. On two separate days, maximal muscle strength of the knee extensors was determined quantitatively using a dynamometer. On both days, muscle strength was determined before a constant blood glucose level was obtained and after the blood glucose level had been kept constant at either 5 or 16 mmol/l for 3 h. Percentage of change from baseline at the two glycaemic levels were calculated and compared. In addition, the changes from baseline at these glycaemic levels were related to glucose turnover.
RESULTS: Following hyperglycaemia, a significant decrease in maximal isometric muscle strength was found as compared with normoglycaemia (86 vs. 104% of the initial level) (P = 0.018). In contrast, no alteration of maximal isokinetic muscle strength was found comparing normo- and hyperglycaemia (96 and 95%) (P = 0.74). Changes in muscle strength were not significantly related to either basal or hyperglycaemic glucose turnover.
CONCLUSIONS: A few hours of hyperglycaemia in Type 1 diabetic patients leads to a reduction of isometric muscle performance, whereas isokinetic muscle strength is unchanged. The reduction in muscle strength could play a role in the development of fatigue and is related more closely to ambient glucose concentrations than to systemic glucose availability.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176203     DOI: 10.1111/j.1464-5491.2005.01649.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  21 in total

Review 1.  Diabetes pharmacotherapy and effects on the musculoskeletal system.

Authors:  Evangelia Kalaitzoglou; John L Fowlkes; Iuliana Popescu; Kathryn M Thrailkill
Journal:  Diabetes Metab Res Rev       Date:  2018-12-20       Impact factor: 4.876

2.  Myostatin serum levels in children with type 1 diabetes mellitus.

Authors:  Alexandra Efthymiadou; Ioannis-Anargyros Vasilakis; Aristeidis Giannakopoulos; Dionisios Chrysis
Journal:  Hormones (Athens)       Date:  2021-09-06       Impact factor: 2.885

3.  Motor performance during and following acute alcohol intoxication in healthy non-alcoholic subjects.

Authors:  M B Poulsen; J Jakobsen; N K Aagaard; H Andersen
Journal:  Eur J Appl Physiol       Date:  2007-08-24       Impact factor: 3.078

Review 4.  Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications.

Authors:  Samantha K Coleman; Irena A Rebalka; Donna M D'Souza; Thomas J Hawke
Journal:  World J Diabetes       Date:  2015-12-10

5.  Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study.

Authors:  Karen M Rothacker; Sam Armstrong; Grant J Smith; Nat Benjanuvatra; Brendan Lay; Peter Adolfsson; Timothy W Jones; Paul A Fournier; Elizabeth A Davis
Journal:  Diabetologia       Date:  2021-05-04       Impact factor: 10.122

Review 6.  Diabetic myopathy: impact of diabetes mellitus on skeletal muscle progenitor cells.

Authors:  Donna M D'Souza; Dhuha Al-Sajee; Thomas J Hawke
Journal:  Front Physiol       Date:  2013-12-20       Impact factor: 4.566

7.  Experimentally induced diabetes causes glial activation, glutamate toxicity and cellular damage leading to changes in motor function.

Authors:  Aarti Nagayach; Nisha Patro; Ishan Patro
Journal:  Front Cell Neurosci       Date:  2014-10-31       Impact factor: 5.505

8.  Type-I diabetes aggravates post-hemorrhagic stroke cognitive impairment by augmenting oxidative stress and neuroinflammation in mice.

Authors:  Ghaith A Bahader; Kevin M Nash; Daniyah A Almarghalani; Qasim Alhadidi; Marcia F McInerney; Zahoor A Shah
Journal:  Neurochem Int       Date:  2021-08-01       Impact factor: 4.297

9.  Celastrol attenuates oxidative stress in the skeletal muscle of diabetic rats by regulating the AMPK-PGC1α-SIRT3 signaling pathway.

Authors:  Yue Guan; Zi-Jian Cui; Bei Sun; Li-Ping Han; Chun-Jun Li; Li-Ming Chen
Journal:  Int J Mol Med       Date:  2016-04-05       Impact factor: 4.101

10.  Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds.

Authors:  Mohammad Hassan Baig; Arif Tasleem Jan; Gulam Rabbani; Khurshid Ahmad; Jalaluddin M Ashraf; Taeyeon Kim; Han Sol Min; Yong Ho Lee; Won-Kyung Cho; Jin Yeul Ma; Eun Ju Lee; Inho Choi
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.